{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:50:17Z","timestamp":1768693817768,"version":"3.49.0"},"reference-count":82,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL134366"],"award-info":[{"award-number":["R01HL134366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL158951"],"award-info":[{"award-number":["R01HL158951"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA221813"],"award-info":[{"award-number":["R01CA221813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK120866"],"award-info":[{"award-number":["DK120866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL118808"],"award-info":[{"award-number":["HL118808"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Robust activation of mTOR (mammalian target of rapamycin) signaling in diabetes exacerbates myocardial injury following lethal ischemia due to accelerated cardiomyocyte death with cardiac remodeling and inflammatory responses. We examined the effect of rapamycin (RAPA, mTOR inhibitor) on cardiac remodeling and inflammation following myocardial ischemia\/reperfusion (I\/R) injury in diabetic rabbits. Diabetic rabbits (DM) were subjected to 45 min of ischemia and 10 days of reperfusion by inflating\/deflating a previously implanted hydraulic balloon occluder. RAPA (0.25 mg\/kg, i.v.) or DMSO (vehicle) was infused 5 min before the onset of reperfusion. Post-I\/R left ventricular (LV) function was assessed by echocardiography and fibrosis was evaluated by picrosirius red staining. Treatment with RAPA preserved LV ejection fraction and reduced fibrosis. Immunoblot and real-time PCR revealed that RAPA treatment inhibited several fibrosis markers (TGF-\u03b2, Galectin-3, MYH, p-SMAD). Furthermore, immunofluorescence staining revealed the attenuation of post-I\/R NLRP3-inflammasome formation with RAPA treatment as shown by reduced aggregation of apoptosis speck-like protein with a caspase recruitment domain and active-form of caspase-1 in cardiomyocytes. In conclusion, our study suggests that acute reperfusion therapy with RAPA may be a viable strategy to preserve cardiac function with the alleviation of adverse post-infarct myocardial remodeling and inflammation in diabetic patients.<\/jats:p>","DOI":"10.3390\/ijms24108998","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T10:35:11Z","timestamp":1684492511000},"page":"8998","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-2553","authenticated-orcid":false,"given":"Arun","family":"Samidurai","sequence":"first","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Saravanan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzi","family":"Ockaili","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatas","family":"Kraskauskas","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suet Ying Valerie","family":"Lau","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Kodali","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakthi","family":"Ramasamy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthikeya","family":"Bhoopathi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Nair","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean K.","family":"Roh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh C.","family":"Kukreja","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-7277","authenticated-orcid":false,"given":"Anindita","family":"Das","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pauley Heart Center, Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/CLEP.S200173","article-title":"Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus","volume":"11","author":"Gyldenkerne","year":"2019","journal-title":"Clin. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-016-0470-x","article-title":"Impact of diabetes on the predictive value of heart failure biomarkers","volume":"15","author":"Alonso","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/5584_2017_105","article-title":"Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy","volume":"1067","author":"Alonso","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2022.03.010","article-title":"Co-administration of hydrogen and metformin exerts cardioprotective effects by inhibiting pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"183","author":"Zou","year":"2022","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-015-0486-5","article-title":"Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling","volume":"110","author":"Das","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/cvr\/cvz315","article-title":"STAT3-miR-17\/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice","volume":"116","author":"Samidurai","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1111\/bph.14059","article-title":"Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia\/reperfusion injury","volume":"174","author":"Samidurai","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.yjmcc.2012.09.007","article-title":"Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway","volume":"53","author":"Das","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4619720","DOI":"10.1155\/2017\/4619720","article-title":"Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK","volume":"2017","author":"Filippone","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2006.04.014","article-title":"Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes","volume":"41","author":"Khan","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.113.003638","article-title":"Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage","volume":"128","author":"Konstandin","year":"2013","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1074\/jbc.M113.521062","article-title":"Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: Potential role of attenuated oxidative stress and altered contractile protein expression","volume":"289","author":"Das","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00125-015-3839-6","article-title":"Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice","volume":"59","author":"Shum","year":"2016","journal-title":"Diabetologia"},{"key":"ref_15","first-page":"57","article-title":"PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity","volume":"6","author":"Doroudgar","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101863","DOI":"10.1016\/j.isci.2020.101863","article-title":"Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes","volume":"23","author":"Samidurai","year":"2020","journal-title":"iScience"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ehf2.13754","article-title":"Exacerbated post-infarct pathological myocardial remodelling in diabetes is associated with impaired autophagy and aggravated NLRP3 inflammasome activation","volume":"9","author":"Mao","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"eaav3048","DOI":"10.1126\/scisignal.aav3048","article-title":"mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-beta(1)-induced collagen biosynthesis","volume":"12","author":"Selvarajah","year":"2019","journal-title":"Sci. Signal."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lian, H., Ma, Y., Feng, J., Dong, W., Yang, Q., L\u00fc, D., and Zhang, L. (2012). Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt\/mTor\/p70s6k Pathway. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044946"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2020.03.045","article-title":"Left Ventricular End-Systolic Dimension and Outcome in Patients With Heart Failure Undergoing Percutaneous MitraClip Valve Repair for Secondary Mitral Regurgitation","volume":"126","author":"Debonnaire","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.120.051517","article-title":"Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction","volume":"143","author":"Snider","year":"2021","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","article-title":"Myocardial remodeling after infarction: The role of myofibroblasts","volume":"7","author":"Borne","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e31756","DOI":"10.7554\/eLife.31756","article-title":"TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition","volume":"7","author":"Ramachandran","year":"2018","journal-title":"eLife"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","article-title":"Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling","volume":"116","author":"Bujak","year":"2007","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biocel.2015.10.012","article-title":"Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-beta1\/Smad activation in cardiac fibroblasts","volume":"69","author":"Chen","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: A novel mediator of heart failure development and progression","volume":"11","author":"Voors","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_33","first-page":"278","article-title":"Global longitudinal strain as a biomarker in diabetic cardiomyopathy. A comparative study with Gal-3 in patients with preserved ejection fraction","volume":"87","year":"2017","journal-title":"Arch. Cardiol. Mex."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jacc.2015.04.026","article-title":"Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal","volume":"65","author":"Lopez","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6976153","DOI":"10.1155\/2020\/6976153","article-title":"Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis","volume":"2020","author":"Lebedev","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23081","DOI":"10.1038\/s41598-021-02508-4","article-title":"Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis","volume":"11","author":"Kremastiotis","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12011-019-01902-4","article-title":"Zinc Deficiency Promoted Fibrosis via ROS and TIMP\/MMPs in the Myocardium of Mice","volume":"196","author":"Cao","year":"2020","journal-title":"Biol. Trace Element Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/jmcc.1999.1052","article-title":"Effects of Gene Deletion of the Tissue Inhibitor of the Matrix Metalloproteinase-type 1 (TIMP-1) on Left Ventricular Geometry and Function in Mice","volume":"32","author":"Roten","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"H149","DOI":"10.1152\/ajpheart.00370.2004","article-title":"Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: Effects of exogenous MMP inhibition","volume":"288","author":"Ikonomidis","year":"2005","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.49.2.525","article-title":"Myosin isoenzyme changes in several models of rat cardiac hypertrophy","volume":"49","author":"Mercadier","year":"1981","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0006-291X(03)00478-9","article-title":"Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart","volume":"303","author":"Razeghi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","article-title":"Alpha-myosin heavy chain: A sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy","volume":"112","author":"Carniel","year":"2005","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-5793(80)80219-5","article-title":"The ATPase activities of rat cardiac myosin isoenzymes","volume":"118","author":"Pope","year":"1980","journal-title":"FEBS Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI115675","article-title":"Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium","volume":"89","author":"Takahashi","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_45","first-page":"H473","article-title":"Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats","volume":"260","author":"Buttrick","year":"1991","journal-title":"Am. J. Physiol. Content"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H1814","DOI":"10.1152\/ajpheart.2001.280.4.H1814","article-title":"Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles","volume":"280","author":"Reiser","year":"2001","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/15548627.2022.2115675","article-title":"NPPA\/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart","volume":"19","author":"Forte","year":"2023","journal-title":"Autophagy"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1440-1681.2003.03836.x","article-title":"Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice","volume":"30","author":"Feng","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardiores.2003.12.005","article-title":"Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse","volume":"61","author":"Mori","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1073\/pnas.94.26.14730","article-title":"Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A","volume":"94","author":"Oliver","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI11273","article-title":"Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A\u2013deficient mice","volume":"107","author":"Knowles","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1253\/circj.67.443","article-title":"Administration of Atrial Natriuretic Peptide Attenuates Reperfusion Phenomena and Preserves Left Ventricular Regional Wall Motion After Direct Coronary Angioplasty for Acute Myocardial Infarction","volume":"67","author":"Kuga","year":"2003","journal-title":"Circ. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehn206","article-title":"Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction","volume":"29","author":"Kasama","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(01)01233-5","article-title":"Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"37","author":"Hayashi","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-0004.1976.tb00008.x","article-title":"A linkage study of the Marfan syndrome","volume":"10","author":"Murdoch","year":"1976","journal-title":"Clin. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","article-title":"Deletion of the Angiotensin Type 2 Receptor (AT2R) Reduces Adipose Cell Size and Protects From Diet-Induced Obesity and Insulin Resistance","volume":"54","author":"Even","year":"2005","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00005344-198611000-00005","article-title":"Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans","volume":"8","author":"Uehlinger","year":"1986","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/acsptsci.9b00064","article-title":"The Role of Bone Morphogenetic Proteins in Diabetic Complications","volume":"3","author":"Perera","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1038\/s41598-017-17595-5","article-title":"BMPs as new insulin sensitizers: Enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARgamma and GLUT4 upregulation","volume":"7","author":"Schreiber","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1479-5876-10-145","article-title":"Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice","volume":"10","author":"Wang","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1096\/fj.201902692R","article-title":"Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-beta1\/Smads signaling in diabetic cardiomyopathy","volume":"34","author":"Che","year":"2020","journal-title":"FASEB J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death Differ."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell Death, Damage-Associated Molecular Patterns, and Sterile Inflammation in Cardiovascular Disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","article-title":"Oxidative stress and myocardial injury in the diabetic heart","volume":"229","author":"Ansley","year":"2013","journal-title":"J. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"748183","DOI":"10.3389\/fcvm.2022.748183","article-title":"Glucose Fluctuations Aggravate Myocardial Fibrosis via the Nuclear Factor-kappaB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9743280","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia\/Reperfusion Injury in Diabetic Rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"768214","DOI":"10.3389\/fcvm.2021.768214","article-title":"Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia\/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy","volume":"8","author":"Yu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"289614","DOI":"10.1155\/2010\/289614","article-title":"Creating a Long-Term Diabetic Rabbit Model","volume":"2010","author":"Wang","year":"2010","journal-title":"Exp. Diabetes Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2006.11.026","article-title":"Surgical animal models of heart failure related to coronary heart disease","volume":"74","author":"Klocke","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0008-6363(99)00274-6","article-title":"Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice","volume":"45","author":"Gao","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"504037","DOI":"10.1155\/2012\/504037","article-title":"Long-Term Left Ventricular Remodelling in Rat Model of Nonreperfused Myocardial Infarction: Sequential MR Imaging Using a 3T Clinical Scanner","volume":"2012","author":"Saleh","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10554-008-9393-2","article-title":"A modified rabbit model of reperfused myocardial infarction for cardiac MR imaging research","volume":"25","author":"Feng","year":"2009","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_77","first-page":"358","article-title":"An overview on development and application of an experimental platform for quantitative cardiac imaging research in rabbit models of myocardial infarction","volume":"4","author":"Feng","year":"2014","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7150\/thno.7188","article-title":"Towards Stratifying Ischemic Components by Cardiac MRI and Multifunctional Stainings in a Rabbit Model of Myocardial Infarction","volume":"4","author":"Feng","year":"2013","journal-title":"Theranostics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"754","DOI":"10.21037\/qims.2018.09.05","article-title":"Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging","volume":"8","author":"Feng","year":"2018","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100772","DOI":"10.1016\/j.xpro.2021.100772","article-title":"Preclinical model of type 1 diabetes and myocardial ischemia\/reperfusion injury in conscious rabbits\u2014Demonstration of cardioprotection with rapamycin","volume":"2","author":"Samidurai","year":"2021","journal-title":"STAR Protoc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): A new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circ. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","article-title":"Sacubitril\/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits","volume":"72","author":"Torrado","year":"2018","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8998\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:38:27Z","timestamp":1760125107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24108998"],"URL":"https:\/\/doi.org\/10.3390\/ijms24108998","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}